Addiction

The NSS-2 Bridge relieves withdrawal symptoms for up to 5 days during an acute period.

FDA sends response letter requesting studies to assess abuse-deterrent properties of oxycodone extended release.

The reSET app is the first mobile medical application to treat substance use disorders.

RBP-6000, a injectable buprenorphine for adult moderate-to-severe OUD patients, was submitted for new drug application in May with major consideration to a phase 3 efficacy and safety study.

How the FDA has bolstered its policies and rulings on opioid products in just 2 months under commissioner Scott Gottlieb.

The decision came one month after the first-ever FDA recommendation for a drug withdrawal on the grounds of opioid abuse.

The opioid treatment program's studies yielded positive results.

This comes a week after its first request for a drug removal.

Any amount of prenatal exposure can change development of nose, lips, eyes.

There is significant financial incentive for hospitals to implement an Improving Addiction Care Team, or Project IMPACT.

The opioid-induced deficiency worsens quality of life and body composition.

The guidelines call for a crackdown on chronic non-cancer pain prescriptions.

Approval includes a revised indication for initiation treatment.

Doctors should have an honest discussion with patients who exhibit red flags showing that they should not be given opioids, Larry Greenblatt, MD, of Duke University School of Medicine said at the American College of Physicians Internal Medicine Meeting (ACP 2017) in San Diego, California.

Can anything halt runaway drug prices? ACP asks.

When a patient comes strolling into your office at 4:30 p.m. on a Friday wanting an opioid prescription, that could be a red flag, Suresh Reddy, MD, professor of palliative care at the University of Texas MD Anderson Cancer Center told MD Magazine.

Physicians can play a role in curbing substance misuse.

Pharma submits sNDA for IBS-C drug plecanatide.

Nektar Therapeutics announced favorable phase 3 results for NKTR-181.

Constance Scharff, PhD: it's a bad time to cut access.

Drug problems and emotional issues should be treated at the same time.

The top goal of chronic pain treatment differs between physicians and patients.

Patients taking opioids leading up to surgery have worse outcomes.

Many people on buprenorphine are still receiving opioid prescriptions.

Around 16% to 26% of people using medicinal marijuana consume edible versions.

Nearly 70% of parents aren't keeping opioids latched or locked away.

Medicinal marijuana initiatives were approved in some capacity in 28 states and DC.

The AMA urges officials to remove barrier to addiction treatment.

Early marijuana use can hurt multiple cognitive functions.

Telepsychiatry therapy can be a good add-on to buprenorphine treatment.